» Articles » PMID: 38858467

X-ray Imageable, Drug-loaded Hydrogel That Forms at Body Temperature for Image-guided, Needle-based Locoregional Drug Delivery

Abstract

Liver cancer ranks as the fifth leading cause of cancer-related death globally. Direct intratumoral injections of anti-cancer therapeutics may improve therapeutic efficacy and mitigate adverse effects compared to intravenous injections. Some challenges of intratumoral injections are that the liquid drug formulation may not remain localized and have unpredictable volumetric distribution. Thus, drug delivery varies widely, highly-dependent upon technique. An X-ray imageable poloxamer 407 (POL)-based drug delivery gel was developed and characterized, enabling real-time feedback. Utilizing three needle devices, POL or a control iodinated contrast solution were injected into an ex vivo bovine liver. The 3D distribution was assessed with cone beam computed tomography (CBCT). The 3D distribution of POL gels demonstrated localized spherical morphologies regardless of the injection rate. In addition, the gel 3D conformal distribution could be intentionally altered, depending on the injection technique. When doxorubicin (DOX) was loaded into the POL and injected, DOX distribution on optical imaging matched iodine distribution on CBCT suggesting spatial alignment of DOX and iodine localization in tissue. The controllability and localized deposition of this formulation may ultimately reduce the dependence on operator technique, reduce systemic side effects, and facilitate reproducibility across treatments, through more predictable standardized delivery.

Citing Articles

In vivo imaging and pharmacokinetics of percutaneously injected ultrasound and X-ray imageable thermosensitive hydrogel loaded with doxorubicin versus free drug in swine.

Delgado J, Negussie A, Varble N, Mikhail A, Arrichiello A, Borde T PLoS One. 2024; 19(12):e0310345.

PMID: 39700200 PMC: 11658602. DOI: 10.1371/journal.pone.0310345.


Imaging and Pharmacokinetics of Percutaneously Injected Ultrasound and X-ray Imageable Thermosensitive Hydrogel loaded with Doxorubicin versus Free Drug in Swine.

Delgado J, Negussie A, Varble N, Mikhail A, Arrichiello A, Borde T bioRxiv. 2024; .

PMID: 39282453 PMC: 11398325. DOI: 10.1101/2024.09.01.610710.


Ultrasound and x-ray imageable poloxamer-based hydrogel for loco-regional therapy delivery in the liver.

Delgado J, Owen J, Pritchard W, Varble N, Lopez-Silva T, Mikhail A Sci Rep. 2024; 14(1):20455.

PMID: 39227382 PMC: 11372101. DOI: 10.1038/s41598-024-70992-5.


Ultrasound and x-ray imageable poloxamer-based hydrogel for loco-regional therapy delivery in the liver.

Delgado J, Owen J, Pritchard W, Varble N, Lopez-Silva T, Mikhail A Res Sq. 2024; .

PMID: 38978563 PMC: 11230504. DOI: 10.21203/rs.3.rs-4555123/v1.

References
1.
Fathi M, Alami-Milani M, Geranmayeh M, Barar J, Erfan-Niya H, Omidi Y . Dual thermo-and pH-sensitive injectable hydrogels of chitosan/(poly(N-isopropylacrylamide-co-itaconic acid)) for doxorubicin delivery in breast cancer. Int J Biol Macromol. 2019; 128:957-964. DOI: 10.1016/j.ijbiomac.2019.01.122. View

2.
Kim S, Bae Y, Okano T . Hydrogels: swelling, drug loading, and release. Pharm Res. 1992; 9(3):283-90. DOI: 10.1023/a:1015887213431. View

3.
Yan C, Altunbas A, Yucel T, Nagarkar R, Schneider J, Pochan D . Injectable solid hydrogel: mechanism of shear-thinning and immediate recovery of injectable β-hairpin peptide hydrogels. Soft Matter. 2011; 6(20):5143-5156. PMC: 3091287. DOI: 10.1039/C0SM00642D. View

4.
Hassan R, Alewine C, Mian I, Spreafico A, Siu L, Gomez-Roca C . Phase 1 study of the immunotoxin LMB-100 in patients with mesothelioma and other solid tumors expressing mesothelin. Cancer. 2020; 126(22):4936-4947. PMC: 8552963. DOI: 10.1002/cncr.33145. View

5.
Sudheendra D, Leger R, Groppo E, Sun D, Durrani A, Neeman Z . Comparison of three different needles for percutaneous injections. Cardiovasc Intervent Radiol. 2006; 30(1):151-2. PMC: 2555975. DOI: 10.1007/s00270-005-0387-3. View